RUNX1 and acute myeloid leukemia: Thus, according to the results of this cohort, previously reported characteristic features, favouring the concept of considering RUNX1-mutated AML as a distinct entity [13, 17], cannot be confirmed in paediatric AML since RUNX1 mutation lacks these mutational features and overlaps with AML defining mutational patterns.